Thomas G - Search Results

1

CD40 agonist-induced IL-12p40 potentiates hepatotoxicity.

Bonnans C, Thomas G, He W, Jung B, Chen W, Liao M, Heyen J, Buetow B, Pillai S, Matsumoto D, Chaparro-Riggers J, Salek-Ardakani S, Qu Y. Bonnans C, et al. Among authors: thomas g. J Immunother Cancer. 2020 May;8(1):e000624. doi: 10.1136/jitc-2020-000624. J Immunother Cancer. 2020. PMID: 32474414 Free PMC article.

2

CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.

Marcovecchio PM, Thomas G, Salek-Ardakani S. Marcovecchio PM, et al. Among authors: thomas g. J Immunother Cancer. 2021 Feb;9(2):e002045. doi: 10.1136/jitc-2020-002045. J Immunother Cancer. 2021. PMID: 33637602 Free PMC article. Review.

3

Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment.

Qu Y, Wen J, Thomas G, Yang W, Prior W, He W, Sundar P, Wang X, Potluri S, Salek-Ardakani S. Qu Y, et al. Among authors: thomas g. Cell Rep. 2020 Jul 7;32(1):107873. doi: 10.1016/j.celrep.2020.107873. Cell Rep. 2020. PMID: 32640238 Free article.

4

Combinatorial immunotherapy induces tumor-infiltrating CD8⁺ T cells with distinct functional, migratory, and stem-like properties.

Van Braeckel-Budimir N, Dolina JS, Wei J, Wang X, Chen SH, Santiago P, Tu G, Micci L, Al-Khami AA, Pfister S, Ram S, Sundar P, Thomas G, Long H, Yang W, Potluri S, Salek-Ardakani S. Van Braeckel-Budimir N, et al. Among authors: thomas g. J Immunother Cancer. 2021 Dec;9(12):e003614. doi: 10.1136/jitc-2021-003614. J Immunother Cancer. 2021. PMID: 34903555 Free PMC article.

5

Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade.

Budimir N, Thomas GD, Dolina JS, Salek-Ardakani S. Budimir N, et al. Cancer Immunol Res. 2022 Feb;10(2):146-153. doi: 10.1158/2326-6066.CIR-21-0515. Epub 2021 Dec 22. Cancer Immunol Res. 2022. PMID: 34937730 Review.

6

EZH2 as a Regulator of CD8+ T Cell Fate and Function.

Stairiker CJ, Thomas GD, Salek-Ardakani S. Stairiker CJ, et al. Front Immunol. 2020 Oct 6;11:593203. doi: 10.3389/fimmu.2020.593203. eCollection 2020. Front Immunol. 2020. PMID: 33117406 Free PMC article. Review.

7

CD8⁺ T Cell Exhaustion in Cancer.

Dolina JS, Van Braeckel-Budimir N, Thomas GD, Salek-Ardakani S. Dolina JS, et al. Front Immunol. 2021 Jul 20;12:715234. doi: 10.3389/fimmu.2021.715234. eCollection 2021. Front Immunol. 2021. PMID: 34354714 Free PMC article. Review.

8

Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment.

Thomas G, Micci L, Yang W, Katakowski J, Oderup C, Sundar P, Wang X, Geles KG, Potluri S, Salek-Ardakani S. Thomas G, et al. Front Oncol. 2021 Jul 26;11:711673. doi: 10.3389/fonc.2021.711673. eCollection 2021. Front Oncol. 2021. PMID: 34381732 Free PMC article.

9

EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8⁺ T Cells.

Stairiker CJ, Pfister SX, Hendrickson E, Yang W, Xie T, Lee C, Zhang H, Dillon C, Thomas GD, Salek-Ardakani S. Stairiker CJ, et al. Front Immunol. 2021 Nov 24;12:770080. doi: 10.3389/fimmu.2021.770080. eCollection 2021. Front Immunol. 2021. PMID: 34925340 Free PMC article.

10

Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment.

Qu Y, Wen J, Thomas G, Yang W, Prior W, He W, Sundar P, Wang X, Potluri S, Salek-Ardakani S. Qu Y, et al. Among authors: thomas g. Cell Rep. 2020 Sep 1;32(9):108115. doi: 10.1016/j.celrep.2020.108115. Cell Rep. 2020. PMID: 32877666 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,038 results

Search Page